Search Within

Sandra Pierina D'Angelo

  1. "Biostatistics Service"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (33)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (70)
  2. Department of Medicine (70)
  3. Epidemiology and Biostatistics (70)
  4. Hematologic Malignancies, Division of (70)
  5. Sarcoma Service (70)
  6. Solid Tumor Oncology Division (70)

More Groups

People
  1. Mark Dickson (58)
  2. William Tap (56)
  3. Mrinal Gounder (52)
  4. Li-Xuan Qin (51)
  5. Mary Keohan (51)
  6. Ping Chi (42)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (33)
  2. Clinical Cancer Research (8)
  3. Annals of Oncology (3)
  4. JAMA Oncology (3)
  5. Journal of Thoracic Oncology (3)
  6. The Oncologist (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (9)
  3. Elsevier Inc. (9)
  4. Oxford University Press (6)
  5. American Medical Association (3)
  6. Nature Publishing Group (3)

More Publishers

Results (70)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Journal Article

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Dickson, M.; Gounder, M.; Keohan, M. L.; Chi, P.; Kelly, C.; Movva, S.; Nacev, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of NKTR214 and nivolumab in patients with sarcomas
    Meeting Abstract

    D'Angelo, S. P.; Conley, A. P.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Keohan, M. L.; Livingston, J. A.; Patel, S.; Adamson, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save